Page 2 - 2022 DMOH Year-End Review Summary

2022

Message from

Dr. Amit Oza

We are pleased to share with you a Division of Medical
Oncology and Hematology (DMOH) 2022 Year in Review
summary. This summary includes staffing updates,
awards, educational achievements, grants and funding,
promotions, new babies and content from the American
Society of Clinical Oncology (ASCO) Annual Meeting,
European Society for Medical Oncology (ESMO) Congress
and American Society of Hematology (ASH) Annual
Meeting and Exposition.

I personally want to express my gratitude and thanks to
our faculty, fellows, research staff, clinical administra-
tive staff, managers, physician assistants, clinical asso-
ciates, hospitalists and residents for collaborating and
improving clinical care, quality, education and research.
I also want to acknowledge and thank our DMOH leader-
ship teams for the work they have put into leading major
initiatives and programs. Congratulations to all for your
incredible accomplishments this year!
Warm regards,

Dr. Amit M. Oza
Professor of Medicine, University of Toronto
Head, Division of Medical Oncology and Hematology
Director, Cancer Clinical Research Unit
Director, Bras Drug Development Program